| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
MNMD (MNMD) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. MNMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 778.5K | $10.23M | - | |
| CFO | 500.0K | - | - | |
| Other | 425.0K | $5.59M | - | |
| Other | 282.6K | $3.71M | - | |
| Dir | 75.2K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Barrow Robert | Chief Executive Officer | Sell | 13,237 | $3.63 | $48,050.31 | -2.2% | |
| Dec 26, 2023 | Greenway Schond L. | Chief Financial Officer | Sell | 5,652 | $3.63 | $20,516.76 | -2.5% | |
| Sep 25, 2023 | Barrow Robert | Chief Executive Officer | Sell | 13,499 | $3.58 | $48,273.74 | -1.1% | |
| Sep 25, 2023 | Karlin Dan | Chief Medical Officer | Sell | 6,918 | $3.57 | $24,729.66 | -0.9% | |
| Sep 25, 2023 | Greenway Schond L. | Chief Financial Officer | Sell | 5,762 | $3.58 | $20,608.88 | -1.3% | |
| Aug 25, 2023 | Greenway Schond L. | Chief Financial Officer | Sell | 20,000 | $3.80 | $76,000.00 | -8.1% | |
| Jun 27, 2023 | Barrow Robert | Chief Executive Officer | Sell | 15,502 | $3.20 | $49,619.70 | -1.2% | |
| Jun 27, 2023 | Karlin Dan | Chief Medical Officer | Sell | 6,783 | $3.20 | $21,697.03 | -0.9% | |
| Jun 27, 2023 | Greenway Schond L. | Chief Financial Officer | Sell | 11,635 | $3.20 | $37,194.47 | -2.3% | |
| Mar 1, 2023 | Karlin Dan | Chief Medical Officer | Sell | 3,577 | $3.51 | $12,555.27 | -1.4% |